
Glimepiride (3mg)
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimcip 3 Tablet contains Glimepiride 3mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby lowering blood glucose levels. Glimepiride enhances peripheral insulin sensitivity and reduces hepatic glucose production, contributing to improved glycemic control. This medication is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise, and may be used alone or in combination with other antidiabetic agents. The usual dosage is individualized based on patient response and glycemic targets, with careful monitoring to minimize the risk of hypoglycemia, a common adverse effect. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Patients should be educated on recognizing symptoms of hypoglycemia and advised to maintain regular blood glucose monitoring. Glimcip 3 Tablet should be taken orally with meals to reduce gastrointestinal discomfort. Regular follow-up is essential to assess therapeutic efficacy and adjust dosage accordingly to achieve optimal glycemic control while minimizing side effects.
How to use Glimcip Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimcip 3 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimcip 3 Tablet.
High Risk
Glimcip 3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimcip 3 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimcip 3 Tablet may be needed. Please consult your doctor. However, the use of Glimcip 3 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimcip 3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimcip 3 Tablet
Consult Doctor
Glimcip 3 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimcip 3 Tablet may be needed. Please consult your doctor. Use of Glimcip 3 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimcip 3 Tablet

Glimepiride (3mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimcip 3 Tablet contains Glimepiride 3mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions by stimulating pancreatic beta cells to release insulin, thereby lowering blood glucose levels. Glimepiride enhances peripheral insulin sensitivity and reduces hepatic glucose production, contributing to improved glycemic control. This medication is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise, and may be used alone or in combination with other antidiabetic agents. The usual dosage is individualized based on patient response and glycemic targets, with careful monitoring to minimize the risk of hypoglycemia, a common adverse effect. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to sulfonylureas. Patients should be educated on recognizing symptoms of hypoglycemia and advised to maintain regular blood glucose monitoring. Glimcip 3 Tablet should be taken orally with meals to reduce gastrointestinal discomfort. Regular follow-up is essential to assess therapeutic efficacy and adjust dosage accordingly to achieve optimal glycemic control while minimizing side effects.
How to use Glimcip Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimcip 3 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimcip 3 Tablet.
High Risk
Glimcip 3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimcip 3 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimcip 3 Tablet may be needed. Please consult your doctor. However, the use of Glimcip 3 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimcip 3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimcip 3 Tablet
Consult Doctor
Glimcip 3 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimcip 3 Tablet may be needed. Please consult your doctor. Use of Glimcip 3 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimcip 3 Tablet













